{"version":"1.0","provider_name":"Pharma Trend","provider_url":"https:\/\/pharma-trend.com\/en","author_name":"Business Wire","author_url":"https:\/\/pharma-trend.com\/en\/author\/business\/","title":"Wellbeing Provides Bi-Weekly Default Status Report - Pharma Trend","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"nuIvJFRPTN\"><a href=\"https:\/\/pharma-trend.com\/en\/wellbeing-provides-bi-weekly-default-status-report\/\">Wellbeing Provides Bi-Weekly Default Status Report<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/pharma-trend.com\/en\/wellbeing-provides-bi-weekly-default-status-report\/embed\/#?secret=nuIvJFRPTN\" width=\"600\" height=\"338\" title=\"&#8220;Wellbeing Provides Bi-Weekly Default Status Report&#8221; &#8212; Pharma Trend\" data-secret=\"nuIvJFRPTN\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/pharma-trend.com\/en\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"VANCOUVER, British Columbia&#8211;(BUSINESS WIRE)&#8211;$KONEF #psychedelics&#8211;Wellbeing Digital Sciences Inc. (\u201cWellbeing\u201d or the \u201cCompany\u201d) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2) is providing this update with respect to the management cease trade order (\u201cMCTO\u201d) issued by the British Columbia Securities Commission (\u201cBCSC\u201d) on January 31, 2023, as previously announced by the Company on February 1, 2023 (the \u201cDefault ... [Read more...]","thumbnail_url":"https:\/\/mms.businesswire.com\/media\/20230216005867\/en\/1716538\/21\/61eb51c1cab991b7cbdd437e_Wellbeing_-_2col.jpg"}